Scientists evaluated the effects of glial cell therapy by injecting it into the brains of mice with brain damage similar to that seen in humans in the early to middle stages of dementia. In the future, if the therapy is shown to be safe and effective through clinical trials in humans, the researchers envision it becoming an “off-the-shelf” product for people with early signs of white matter stroke.